Early release of mitochondrial cytochrome c and expression of mitochondrial epitope 7A6 with a porphyrin-derived photosensitizer: Bcl-2 and Bcl-X(L) overexpression do not prevent early mitochondrial events but still depress caspase activity

Laboratory Investigation

Volumn 79, Issue 8, 1999, Pages 953-965

  Carthy, Christopher M ^a,b   Granville, David J ^a,b   Jiang, Huijun ^b   Levy, Julia G ^b   Rudin, Charles M ^c   Thompson, Craig B ^c   McManus, Bruce M ^a   Hunt, David W C ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b QLT PhotoTherapeutics Inc   (Canada)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; CASPASE; CYTOCHROME C; EPITOPE; PHOTOSENSITIZING AGENT; PORPHYRIN; PROTEIN BCL 2; PROTEIN BCL X;

APOPTOSIS; ARTICLE; CELL DEATH; CELL VIABILITY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME SUBSTRATE; EPITOPE MAPPING; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL; PROTEIN FAMILY;

ANIMALS; APOPTOSIS; BCL-X PROTEIN; CASPASES; CELL SURVIVAL; CYTOCHROME C GROUP; EPITOPES; FLOW CYTOMETRY; HELA CELLS; HUMANS; MICE; MITOCHONDRIA; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 0032773849     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Adams JM and Cory S (1998). The Bcl-2 protein family: Arbiters of cell survival. Science 281:1322-1326.
2. Anholt RR, Pedersen PL, De Souza EB, and Snyder SH (1986). The peripheral-type benzodiazepine receptor. Localization to the mitochondrial outer membrane. J Biol Chem 261:576-583.
3. Bossy-Wetzel E, Newmeyer DD, and Green DR (1998). Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMBO J 17:37-49.
4. Cai J and Jones DP (1998). Superoxide in apoptosis. Mitochondrial generation triggered by cytochrome c loss. J Biol Chem 273:11401-11404.
5. Carayon P, Portier M, Dussossoy D, Bord A, Petitpretre G, Canat X, Le Fur G, and Casellas P (1996). Involvement of peripheral benzodiazepine receptors in the protection of hematopoietic cells against oxygen radical damage. Blood 87:3170-3178.
6. Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E, Frisch S, and Reed JC (1998). Regulation of cell death protease caspase-9 by phosphorylation. Science 282:1318-1321.
7. Chao DT, Linette GP, Boise LH, White LS, Thompson CB, and Korsemeyer SJ (1995). Bcl-XL and Bcl-2 repress a common pathway of cell death. J Exp Med 182:821-828.
8. Chauhan D, Pandey P, Ogata A, Teoh G, Krett N, Halgren R, Rosen S, Kufe D, Kharbanda S, and Anderson K (1997). Cytochrome c-dependent and -independent induction of apoptosis in multiple myeloma cells. J Biol Chem 272:29995-29997.
9. Chen Q, Takeyama N, Brady G, Watson AJ, and Dive C (1998). Blood cells with reduced mitochondrial membrane potential and cytosolic cytochrome C can survive and maintain clonogenicity given appropriate signals to suppress apoptosis. Blood 92:4545-4553.
10. Chinnaiyan AM, O'Rourke K, Lane BR, and Dixit VM (1997). Interaction of CED-4 with CED-3 and CED-9: A molecular framework for cell death. Science 275:1122-1126.
11. Ferrari D, Stepczynska A, Los M, Wesselborg S, and Schulze-Osthoff K (1998). Differential regulation and ATP requirement for caspase-8 and caspase-3 activation during CD95-and anticancer drug-induced apoptosis. J Exp Med 188: 979-984.
12. Fuhlbrigge RC, Fine SM, Unanue ER, and Chaplin DD (1988). Expression of membrane interleukin 1 by fibroblasts transfected with murine pro-interleukin 1 alpha cDNA. Proc Natl Acad Sci USA 85:5649-5653.
13. Granville DJ, Carthy CM, Jiang H, Shore GC, McManus BM, and Hunt DW (1998a). Rapid cytochrome c release, activation of caspases 3:6, 7 and 8 followed by Bap31 cleavage in HeLa cells treated with photodynamic therapy. FEBS Lett 437:5-10.
14. Granville DJ, Jiang H, An MT, Levy JG, McManus BM, and Hunt DW (1998b). Overexpression of Bcl-X(L) prevents caspase-3-mediated activation of DNA fragmentation factor (DFF) produced by treatment with the photochemotherapeutic agent BPD-MA. FEBS Lett 422:151-154.
15. Granville DJ, Jiang H, An MT, Levy JG, McManus BM, and Hunt DWC (1998c). Bcl-2 Overexpression blocks caspase activation and downstream apoptotic events instigated by photodynamic therapy. Br J Cancer 79:95-100.
16. Granville DJ, Levy JG, and Hunt DW (1997). Photodynamic therapy induces caspase-3 activation in HL-60 cells. Cell Death Differ 4:623-629.
17. Green DR and Reed JC (1998). Mitochondria and apoptosis. Science 281:1309-1312.
18. Hirsch JD, Beyer CF, Malkowitz L, Loullis CC, and Blume AJ (1989). Characterization of ligand binding to mitochondrial benzodiazepine receptors. Mol Pharmacol 35:164-172.
19. Hirsch T, Decaudin D, Susin SA, Marchetti P, Larochette N, Resche-Rigon M, and Kroemer G (1998). PK11195, a ligand of the mitochondrial benzodiazepine receptor, facilitates the induction of apoptosis and reverses Bcl-2-mediated cytoprotection. Exp Cell Res 241:426-434.
20. Hu Y, Benedict MA, Wu D, Inohara N, and Nunez G (1998). Bcl-XL interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation. Proc Natl Acad Sci USA 95:4386-4391.
21. Jurgensmeier JM, Xie Z, Deveraux Q, Ellerby L, Bredesen D, and Reed JC (1998). Bax directly induces release of cytochrome c from isolated mitochondria. Proc Natl Acad Sci USA 95:4997-5002.
22. Kantrow SP and Piantadosi CA (1997). Release of cytochrome c from liver mitochondria during permeability transition. Biochem Biophys Res Commun 232:669-671.
23. Kharbanda S, Pandey P, Schofield L, Israels S, Roncinske R, Yoshida K, Bharti A, Yuan ZM, Saxena S, Weichselbaum R, Nalin C, and Kufe D (1997). Role for Bcl-xL as an inhibitor of cytosolic cytochrome C accumulation in DNA damage-induced apoptosis. Proc Natl Acad Sci USA 94:6939-6942.
24. Kim CN, Wang X, Huang Y, Ibrado AM, Liu L, Fang G, and Bhalla K (1997). Overexpression of Bcl-X(L) inhibits Ara-C-induced mitochondrial loss of cytochrome c and other perturbations that activate the molecular cascade of apoptosis. Cancer Res 57:3115-3120.
25. Kinnally KW, Zorov DB, Antonenko YN, Snyder SH, McEnery MW, and Tedeschi H (1993). Mitochondrial benzodiazepine receptor linked to inner membrane ion channels by nanomolar actions of ligands. Proc Natl Acad Sci USA 90:1374-1378.
26. Kluck RM, Bossy-Wetzel E, Green DR, and Newmeyer DD (1997). The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis. Science 275: 1132-1136.
27. Koester SK, Roth P, Mikulka WR, Schlossman SF, Zhang C, and Bolton WE (1997). Monitoring early cellular responses in apoptosis is aided by the mitochondrial membrane protein-specific monoclonal antibody APO2.7 Cytometry 29:306-312.
28. Kojima H, Endo K, Moriyama H, Tanaka Y, Alnemri ES, Slapak CA, Teicher B, Kufe D. and Datta R (1998). Abrogation of mitochondrial cytochrome c release and caspase-3 activation in acquired multidrug resistance. J Biol Chem 273: 16647-16650.
29. Kothakota S, Azuma T, Reinhard C, Klippel A, Tang J, Chu K, McGarry TJ, Kirschner MW, Koths K, Kwiatkowski DJ, and Williams LT (1997). Caspase-3-generated fragment of gelsolin: Effector of morphological change in apoptosis. Science 278:294-298.
30. Krajewski S, Tanaka S, Takayama S, Schibler MJ, Fenton W, and Reed JC (1993). Investigation of the subcellular distribution of the bcl-2 oncoprotein: Residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res 53:4701-4714.
31. Kroemer G (1997). The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med 3:614-620.
32. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, and Earnshaw WC (1994). Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371:346-347.
33. Lazebnik YA, Takahashi A, Moir RD, Goldman RD, Poirier GG, Kaufmann SH, and Earnshaw WC (1995). Studies of the lamin proteinase reveal multiple parallel biochemical pathways during apoptotic execution. Proc Natl Acad Sci USA 92:9042-9046.
34. Levy JG (1995). Photodynamic therapy. Trends Biotechnol 13:14-18.
35. Li H, Zhu H, Xu CJ, and Yuan J (1998). Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94:491-501.
36. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, and Wang X (1997). Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91:479-489.
37. Liu X, Kim CN, Yang J, Jemmerson R, and Wang X (1996). Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome-c. Cell 86:147-157.
38. Liu X, Zou H, Slaughter C, and Wang X (1997). DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 89:175-184.
39. Luo X, Budihardjo I, Zou H, Slaughter C, and Wang X (1998). Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94:481-490.
40. Martins LM, Mesner PW, Kottke TJ, Basi GS, Sinha S, Tung JS, Svingen PA, Madden BJ, Takahashi A, McCormick DJ, Earnshaw WC, and Kaufmann SH (1997). Comparison of caspase activation and subcellular localization in HL-60 and K562 cells undergoing etoposide-induced apoptosis. Blood 90:4283-4296.
41. Marzo I, Brenner C, Zamzami N, Jurgensmeier JM, Susin SA, Vieira HLA, Prevost MC, Xie Z, Matsuyama S, Reed JC, and Kroemer G (1998a). Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science 281:2027-2031.
42. Marzo I, Brenner C, Zamzami N, Susin SA, Beutner G, Brdiczka D, Remy R, Xie ZH, Reed JC, and Kroemer G (1998b). The permeability transition pore complex: A target for apoptosis regulation by caspases and bcl-2-related proteins. J Exp Med 187:1261-1271.
43. McEnery MW, Snowman AM, Trifiletti RR, and Snyder SH (1992). Isolation of the mitochondrial benzodiazepine receptor: Association with the voltage-dependent anion channel and the adenine nucleotide carrier. Proc Natl Acad Sci USA 89:3170-3174.
44. Mosmann T (1983). Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 57:55-60.
45. Narita M, Shimizu S, Ito T, Chittenden T, Lutz RJ, Matsuda H, and Tsujimoto Y (1998). Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria. Proc Natl Acad Sci USA 95:14681-14686.
46. Nicholson DW and Thornberry NA (1997). Caspases: Killer proteases. Trends Biochem Sci 22:299-306.
47. Oltvai ZN, Milliman CL, and Korsmeyer SJ (1993). Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609-619.
48. Pan G, Humke EW, and Dixit VM (1998a). Activation of caspases triggered by cytochrome c in vitro. FEBS Lett 426:151-154.
49. Pan GK, O'Rourke K, and Dixit VM (1998b). Caspase-9, Bcl-XL, and Apaf-1 form a ternary complex. J Biol Chem 273:5841-5845.
50. Pastorino JG, Simbula G, Gilfor E, Hoek JB, and Farber JL (1994). Protoporphyrin IX, an endogenous ligand of the peripheral benzodiazepine receptor, potentiates induction of the mitochondrial permeability transition and the killing of cultured hepatocytes by rotenone. J Biol Chem 269:31041-31046.
51. Pastorino JG, Simbula G, Yamamoto K, Glascott PA Jr, Rothman RJ, and Farber JL (1996). The cytotoxicity of tumor necrosis factor depends on induction of the mitochondrial permeability transition. J Biol Chem 271:29792-29798.
52. Ponka P (1997). Tissue-specific regulation of iron metabolism and heme synthesis: Distinct control mechanisms in erythroid cells. Blood 89:1-25.
53. Reed JC (1997a). Cytochrome c: Can't live with it - can't live without it. Cell 91:559-562.
54. Reed JC (1997b). Double identity for proteins of the Bcl-2 family. Nature 387:773-776.
55. Skorski T, Bellacosa A, Nieborowska-Skorska M, Majewski M, Martinez R, Choi JK, Trotta R, Wlodarski P, Perrotti D, Chan TO, Wasik MA, Tsichlis PN, and Calabretta B (1997). Transformation of hematopoietic cells by BCR/ABL requires activation of a Pl-3k/Akt-dependent pathway. EMBO J 16: 6151-6161.
56. Szabo I, De Pinto V, and Zoratti M (1993). The mitochondrial permeability transition pore may comprise VDAC molecules. II. The electrophysiological properties of VDAC are compatible with those of the mitochondrial megachannel. FEBS Lett 330:206-210.
57. Toyoshima F, Moriguchi T, and Nishida E (1997). Fas induces cytoplasmic apoptotic responses and activation of the MKK7-JNK/SAPK and MKK6-p38 pathways independent of CPP32-like proteases. J Cell Biol 139:1005-1015.
58. Vanags DM, Porn-Ares MI, Coppola S, Burgess DH, and Orrenius S (1996). Protease involvement in fodrin cleavage and phosphatidylserine exposure in apoptosis. J Biol Chem 271:31075-31085.
59. Vander Heiden MG, Chandel NS, Williamson EK, Schumacker PT, and Thompson C. B (1997). Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria. Cell 91:627-637.
60. Verma A, Facchina SL, Hirsch DJ, Song SY, Dillahey LF, Williams JR, and Snyder SH (1998). Photodynamic tumor therapy: Mitochondrial benzodiazepine receptors as a therapeutic target. Mol Med 4:40-45.
61. Verma A, Nye JS, and Snyder SH (1987). Porphyrins are endogenous ligands for the mitochondrial (peripheral-type) benzodiazepine receptor. Proc Natl Acad Sci USA 84:2256-2260.
62. Wang CY, Mayo MW, Korneluk RG, Goeddel DV, and Baldwin AS Jr (1998). NF-kappaB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281:1680-1683.
63. Weishaupt KR, Gomer CJ, and Dougherty TJ (1976). Identification of singlet oxygen as the cytotoxic agent in photoin-activation of a murine tumor. Cancer Res 36:2326-2329.
64. Wen LP, Fahrni JA, Troie S, Guan JL, Orth K, and Rosen GD (1997). Cleavage of focal adhesion kinase by caspases during apoptosis. J Biol Chem 272:26056-26061.
65. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP, and Wang X (1997). Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked. Science 275:1129-1132.
66. Zamzami N, Marchetti P, Castedo M, Decaudin D, Macho A, Hirsch T, Susin SA, Petit PX, Mignotte B, and Kroemer G (1995). Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. Cell 82:405-414.
67. Zamzami N, Susin SA, Marchetti P, Hirsch T, Gomez-Monterrey I, Castedo M, and Kroemer G (1996). Mitochondrial control of nuclear apoptosis. J Exp Med 183:1533-1544.
68. Zhang C, Ao A, Seth A, and Schlossman SF (1996). A mitochondrial membrane protein defined by a novel monoclonal antibody is preferentially detected in apoptotic cells. J Immunol 157:3980-3987.